Zimmer Biomet (NYSE:ZBH – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Needham & Company LLC in a research note issued to investors on Wednesday,Benzinga reports.

Meta Platforms and most other U.S. stocks are rising Thursday following a rush of profit reports from some of the country’s most influential companies, but drops for Nvidia and Microsoft are keeping ...

In 2024, the Summers Value Fund LP (“the Fund”) delivered a net1 return of 27.4%. Click here to read the full letter.

Zimmer Biomet Holdings Inc (NYSE:ZBH), a leading player in the medical devices sector with a market capitalization of $22.12 ...

Zimmer Biomet Holdings, Inc. plans to acquire a Colorado-based business with "an extensive suite of surgical offerings and product systems spanning all major foot and ankle segments." ...

Paragon 28 has reported net revenue for the full year of 2024 in the range of $255.9 to $256.2 million, representing 18.2% to ...

Zimmer Biomet has entered into a definitive agreement to purchase Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics.

Paragon 28 shares rose 8.4% after Zimmer Biomet Holdings agreed to acquire the company. Shares were trading around $13.02. The stock is up about 2.6% over the last year.

U.S. stock indexes slipped Wednesday after the Federal Reserve opted not to cut interest rates for the first time since it began trying to help the economy through easier rates in September. The S&P ...

Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...

Zimmer Biomet is taking steps to expand its foot and ankle orthopedics business with a $1.1 billion deal to acquire ...

Smith & Nephew's stock has underperformed, driven by ongoing market share losses in hip and knee markets and pricing ...